Anthropic acquires Mithril Medicine, a one-person muscular dystrophy drug company

1. 7:24 PM
   Orange AI@oran_geXPick

   Anthropic acquires one-person drug company Mithril Medicine founded by Cody Tranbarger

   AIOrange AI says Anthropic acquired Mithril Medicine, a one-person company that has developed treatments for two rare forms of muscular dystrophy. According to the quoted Anthropic text, founder Cody Tranbarger used Claude to coordinate 11 external labs and advanced a potential treatment to promising mouse results in under 18 months, with a drug possibly ready for human trials by late 2028. The post also lists Anthropic's 2026 acquisitions of Coefficient Bio and Stainless.

   
2. 6:01 PM
   Andrew Curran@AndrewCurran_XPick

   Anthropic acquires Mithril Medicine, a one-person muscular dystrophy drug company

   AIAnthropic has acquired Mithril Medicine, a one-person company developing treatments for two rare forms of muscular dystrophy, according to a quoted Anthropic post. Its founder, Cody Tranbarger, used Claude to take a possible treatment from idea to promising mouse results in under 18 months. Anthropic says it expects a drug to be ready for human clinical trials as soon as late 2028 if the candidates keep holding up.

   

The trend compares only continuously observed participants, so its scope may be smaller than the current heat total. Hover or tap for hourly heat; use arrow keys with a keyboard.